CIK 0001468929 · <br>Emerging growth company
NEXGEL, INC.
Sign in to watch- Ticker
- NXGL
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 264042544
- Phone
- 215 702-8550
- Business address
- 2150 CABOT BLVD WEST,, SUITE B, LANGHORNE, PA, 19047
- Former names
- NEXGEL, INC., AquaMed Technologies, Inc.
Securities
- NXGL Common Stock Nasdaq
- NXGLW Warrant Nasdaq
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- DEFR14A Other DEFR14A
- DEF 14A Proxy Proxy Statement
- 10-K Report Annual Report
- NT 10-K Other NT 10-K
- 8-K Event Results of operations
- 4 Open-market buy Director bought 23,697 shares at $2.11 ($50,001)
- 4 Open-market buy Director bought 11,848 shares at $2.11 ($24,999)
- 4 Open-market buy Chief Financial Officer bought 47,394 shares at $2.11 ($100,001)
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Other events
- 8-K Event Regulation FD disclosure
- 8-K Event Executive or director change
- 8-K Event Material agreement · Unregistered share sale · Executive or director change
- 4 Open-market buy Director bought 3,885 shares at $2.20 ($8,535)
- 8-K Event Executive or director change
- 8-K Event Regulation FD disclosure
- 8-K Event Material agreement · Acquisition or sale completed · Other events
- 10-Q Report Quarterly Report
Page 8 of 17 · 328 filings